NCT06140576 2023-11-20The Efficacy and Safety of Lenvatinib Combined With Sindilimab and Nab-paclitaxel in the First-line Treatment for Recurrent and Metastatic Triple Negative Breast Cancer: a Phase Ib/IIa Clinical Trial.Zhejiang Cancer HospitalPhase 1/2 Not yet recruiting58 enrolled